US$ 20.25
are glp 1 drugs lifelong GLP-1 a commitment? Dr. Priya Jaisinghani explains 'Lifelong drug': Obesity doctor reveals
Description
20 2 C

In individuals without diabetes, sensations of bloating/fullness are more closely associated with emptying from the distal stomach and antral area as measured by ultrasound (50)

Waist circumference is a reliable indicator of abdominal obesity, and it is considered a risk factor for ASCVD independent of body mass index [91]

Liraglutide (Saxenda, Victoza) Liraglutide was the pioneer in weight-loss management

The GLP-1 drug received FDA approval in late December 2025 and was launched in the US in January (January 2026)